BridgeMD
Tests treatment safety and results for Acupuncture
Official title Acupuncture for ADHD: Acupoint Data Mining, Clinical Effectiveness, and Interviews to Explore Treatment Outcomes.
ClinicalTrials.gov ID: NCT06860763
What this study is testing
What is Chinese herbal medicine?
Chinese herbal medicine is an investigational medicine, given as an once-daily infusion into a vein, being studied as a potential treatment for acupuncture.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study aims to evaluate the efficacy of acupuncture as a treatment for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 6-12 years. Using a mixed-methods approach, the research will triangulate data from acupoint data mining, treatment outcomes assessment, and patient perspectives to provide a comprehensive analysis of acupuncture's potential therapeutic benefits for ADHD.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 6 to 12
You may be able to join if
- Patients will be considered for enrolment if they meet the criteria of:
- A confirmed diagnosis of ADHD based on the DSM-5 criteria for ADHD (Western medical diagnosis) and in accordance with the ADHD Chinese Medicine...
- Aged between 6 and 12 years.
- No use of any other pharmacological treatments (both Western and traditional Chinese medicine) within the two weeks prior to the start of the study.
- An IQ score of greater than 80, as determined by the Raven's Progressive Matrices test.
You likely can't join if
- Patients will be excluded from the study if they meet any of the following criteria:
- Do not meet the inclusion criteria
- Have comorbid psychiatric disorders, severe medical or psychiatric conditions that may interfere with the study (e.g., epilepsy, severe anxiety)...
- Have participated in any other drug clinical trials within the past 3 months.
- Have severe comorbid conditions such as cardiovascular, hepatic, renal, or hematologic diseases.
- Have any other conditions that the researchers believe may interfere with the assessment of treatment how well it works or safety.
See the full eligibility criteria
- Patients will be considered for enrolment if they meet the criteria of:
- A confirmed diagnosis of ADHD based on the DSM-5 criteria for ADHD (Western medical diagnosis) and in accordance with the ADHD Chinese Medicine Clinical Trial Design and Evaluation Technical Guidelines.
- Aged between 6 and 12 years.
- No use of any other pharmacological treatments (both Western and traditional Chinese medicine) within the two weeks prior to the start of the study.
- An IQ score of greater than 80, as determined by the Raven's Progressive Matrices test.
- The participant has not participated in any other clinical trials.
- Patients will be excluded from the study if they meet any of the following criteria:
- Do not meet the inclusion criteria
- Have comorbid psychiatric disorders, severe medical or psychiatric conditions that may interfere with the study (e.g., epilepsy, severe anxiety), pervasive developmental disorders, intellectual disability, or a history...
- Have participated in any other drug clinical trials within the past 3 months.
- Have severe comorbid conditions such as cardiovascular, hepatic, renal, or hematologic diseases.
- Have any other conditions that the researchers believe may interfere with the assessment of treatment how well it works or safety.
The study team makes the final eligibility decision.
Where it's taking place
- Beijing, Chaoyang District, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 6 years to 12 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Beijing, Chaoyang District, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.